Diabetes drug has heart and kidney benefits, researchers find

A common diabetes drug has been found to lower the risk of kidney failure in a new study. The finding has raised some eyebrows since...

Posted: Apr 15, 2019 11:25 AM

A common diabetes drug has been found to lower the risk of kidney failure in a new study. The finding has raised some eyebrows since diabetes is a major cause of kidney failure worldwide.

The risk of kidney failure and cardiovascular-related problems was lowered in patients with type 2 diabetes and kidney disease who took a daily dose of the drug canagliflozin as part of the study published in The New England Journal of Medicine on Sunday.

The study was funded by the pharmaceutical company Janssen, manufacturer of the drug canagliflozin, which has the brand name Invokana.

In March, the company submitted a supplemental new drug application to the US Food and Drug Administration for canagliflozin to be used to reduce the risk of end-stage kidney disease and renal or cardiovascular death in adults with type 2 diabetes and chronic kidney disease.

The study included 4,401 patients, aged 30 and older, with type 2 diabetes and chronic kidney disease. Those patients were randomly assigned at 690 sites in 34 countries to take either canagliflozin or a placebo, from March 2014 through May 2017.

They were followed up with at 3, 13 and 26 weeks, during which the effects of the drug were monitored.

The researchers found that in the canagliflozin group the relative risk of death from renal causes was 34% lower, and the relative risk of end-stage kidney disease was 32% lower. The group also had a lower risk of cardiovascular death, heart attack, stroke and hospitalization for heart failure.

Based on data in the study, the researchers estimated that canagliflozin treatment would prevent 22 hospitalizations for heart failure and 25 composite events of cardiovascular death, heart attack or stroke among 1,000 patients.

As for harmful outcomes, canagliflozin has been found to increase the risk of having a lower limb amputation as a side effect, but the researchers saw no significant difference in the risk of lower-limb amputation between the two groups in the study. Rates of bone fracture, another known side effect of canagliflozin, were also similar in the two groups, according to the study.

The study also showed that risk of diabetic ketoacidosis, a life-threatening problem when the body starts breaking down fat at an unhealthy fast rate, was low overall but higher in the canagliflozin group.

The study had some limitations, including that it did not include patients who had very advanced kidney disease. Nor did it include patients whose kidney diseases were believed to be due to conditions other than type 2 diabetes. More research is needed to determine whether the study's findings could be generalized to other types of kidney disease.

This study has the potential to influence medical practice, said Dr. Mark Molitch, professor of endocrinology at Northwestern University's Feinberg School of Medicine, who was not involved in the new study but often has prescribed canagliflozin for his own patients.

Canagliflozin, a medication used to treat type 2 diabetes, belongs to a class of drugs called sodium-glucose cotransporter-2, or SGLT2 inhibitors, which lower blood sugar by causing kidneys to remove sugar from the body through urine.

"With this whole class of drugs, we really do need to think about how we're using it, because of the heart benefits and the kidney benefits," Molitch said about SGLT2 inhibitors.

"This class of drugs really has its primary action on the kidney, from a diabetes perspective. So normally we have lots of glucose -- the main sugar that's circulating in the blood -- and then the kidney filters that glucose. And so most of the time there's no glucose in the urine because the kidney reabsorbs all the glucose that's filtered out of the blood," he said. "What these drugs do is that they block that reabsorption of glucose back into the blood from the urine. And so then you excrete lots of the glucose out into the urine."

Molitch, a member of the Endocrine Society, added that the heart and kidney benefits described in the new study "are over and above" the benefits of simply lowering blood sugar.

"We're still not exactly sure what the mechanisms are that cause these heart and kidney benefits, but they are clearly not solely due to lowering the blood sugar level," he said.

"The heart and kidney benefits occur in patients with more advanced kidney disease, in whom the blood glucose lowering effects of canagliflozin would be minimal," he said. "So, on the basis of this study, we might use canagliflozin just for kidney benefits and possibly heart benefits while using other drugs to control glucose levels in patients with diabetes and kidney disease."

The effect of the drug "was quite rapid" in the study, Dr. Derek LeRoith, professor of medicine at the Icahn School of Medicine at Mount Sinai in New York, said in an email. Leroith also is a diabetes guidelines chair for the Endocrine Society.

"This trial was designed to include individuals who had diabetic renal disease, and as such, is the first example of a lowering of risk for kidney failures [as] well as improved cardiovascular outcomes," said LeRoith, who was not involved in the study. "I believe the paper is extremely significant and will have a widely read audience with major implications."

Indiana Coronavirus Cases

Data is updated nightly.

Cases: 1000163

Reported Deaths: 16309
CountyCasesDeaths
Marion1347632106
Lake660041156
Allen57441793
Hamilton46100461
St. Joseph44109607
Elkhart35696507
Vanderburgh32087477
Tippecanoe27796257
Johnson24902443
Hendricks23738354
Porter22802362
Madison18614404
Clark18424250
Vigo17347301
Monroe15180197
LaPorte15046250
Delaware14984259
Howard14626287
Kosciusko12217147
Hancock11630175
Bartholomew11505179
Warrick11255189
Floyd11013214
Wayne10897250
Grant9964218
Morgan9404176
Boone8863116
Dubois8227130
Dearborn817093
Henry8139151
Noble7984106
Marshall7838134
Cass7499119
Lawrence7403170
Shelby7138114
Jackson694088
Gibson6533113
Harrison644491
Huntington633999
Knox6273106
DeKalb626397
Montgomery6208109
Miami589797
Putnam575377
Clinton570271
Whitley560455
Steuben554675
Wabash5279101
Jasper524475
Jefferson506996
Ripley495685
Adams476073
Daviess4616113
Scott435869
Greene422096
Wells420987
Clay420260
White415962
Decatur4133101
Fayette404286
Jennings385160
Posey375343
LaGrange353978
Washington353249
Randolph341999
Spencer337342
Fountain332558
Sullivan326752
Starke313369
Owen312070
Fulton306567
Orange291762
Jay280445
Perry264752
Franklin264042
Carroll259132
Rush258832
Vermillion255454
Parke230026
Pike227943
Tipton226659
Blackford190540
Pulaski181855
Crawford158623
Newton156048
Benton150217
Brown144547
Martin137419
Switzerland134211
Warren120516
Union106815
Ohio84112
Unassigned0538

Ohio Coronavirus Cases

Data is updated nightly.

Cases: 1499485

Reported Deaths: 23327
CountyCasesDeaths
Franklin1626291662
Cuyahoga1447662412
Hamilton1044761409
Montgomery731681240
Summit610421094
Lucas55643904
Butler51076707
Stark459431053
Lorain35141568
Warren32476369
Mahoning30315672
Clermont27930321
Lake26669434
Delaware23960162
Licking23547283
Trumbull22550552
Fairfield22179241
Greene22098311
Medina21763305
Clark19630349
Richland18342280
Portage17696247
Wood17244220
Allen15730269
Miami15355296
Muskingum14551174
Columbiana13756263
Wayne13585263
Tuscarawas12479298
Marion11797175
Scioto11388154
Pickaway11286141
Erie10676180
Ross10462196
Lawrence9663137
Hancock9546149
Ashtabula9479197
Belmont9133197
Geauga8829157
Jefferson8481191
Huron8229139
Union810756
Washington8031137
Sandusky7724145
Athens769572
Knox7606138
Darke7553151
Seneca7208144
Ashland6817125
Auglaize667896
Shelby6410111
Brown628582
Crawford6184130
Defiance6087102
Mercer608293
Fulton592996
Highland590099
Madison587576
Clinton576190
Logan574692
Guernsey572467
Preble5660121
Putnam5250108
Williams520184
Perry512561
Champaign505071
Jackson498770
Ottawa479086
Coshocton471582
Morrow451256
Pike430762
Fayette422160
Adams411587
Gallia411265
Hardin411076
Van Wert364078
Henry357871
Holmes3567122
Hocking352578
Wyandot317961
Carroll297059
Paulding275945
Meigs259249
Monroe212953
Noble196546
Morgan190832
Harrison178242
Vinton162624
Unassigned05
Fort Wayne
Clear
48° wxIcon
Hi: 72° Lo: 43°
Feels Like: 46°
Angola
Clear
52° wxIcon
Hi: 70° Lo: 46°
Feels Like: 52°
Huntington
Clear
45° wxIcon
Hi: 72° Lo: 43°
Feels Like: 43°
Decatur
Clear
45° wxIcon
Hi: 72° Lo: 45°
Feels Like: 43°
Van Wert
Partly Cloudy
50° wxIcon
Hi: 72° Lo: 44°
Feels Like: 50°
The wonderful weather continues across the region Tuesday with our next chance of rain midweek.
WFFT Radar
WFFT Temperatures
WFFT National

Community Events